全球行動心電遙測設備市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

預計行動心電遙測設備市場規模將從 2025 年的 20.9 億美元成長到 2034 年的 56.6 億美元，2026 年至 2034 年的複合年成長率為 11.72%。

隨著對遠端患者監護和遠端醫療解決方案的需求持續成長，行動心電遙測設備市場預計將迎來顯著成長。隨著預防保健和慢性病管理的日益重視，行動心電遙測設備正成為醫療服務提供者不可或缺的工具。這些設備能夠持續監測患者的心臟活動，從而實現及時干預並改善患者預後。隨著技術的進步，行動遙測技術與穿戴式裝置和行動應用程式的日益融合將進一步提升心臟護理的可及性和有效性。

隨著全球醫療系統努力降低成本並提高病人參與，行動心電遙測設備為心血管健康管理提供了可行的解決方案。這些設備能夠實現遠端監測，減少患者就診次數，並使醫護人員能夠即時追蹤患者狀況。這項變革不僅提高了病患的便利性，也使醫護人員能夠基於準確及時的數據做出明智的決策。

展望未來，行動心電遙測設備市場可望迎來一系列創新，進而提升設備功能與使用者體驗。數據分析和人工智慧 (AI) 技術的進步將帶來更先進的監測能力，進而實現個人化治療方案和心臟疾病的預防性管理。隨著醫療保健格局的不斷演變，行動心電遙測設備將在塑造心血管護理的未來中發揮關鍵作用，確保患者獲得及時有效的干涉。

目錄

第1章 引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 繪製滲透率和成長前景圖
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制
  • 市場機遇
  • 市場問題
• 波特五力分析
• PESTLE分析

第4章 全球行動心電遙測設備市場（依應用分類）

• 市場分析、洞察與預測
• 鉛基
• 基於補丁

5. 全球行動心電遙測設備市場（依適應症分類）

• 市場分析、洞察與預測
• 心絞痛
• 動脈粥狀硬化
• 心臟衰竭
• 其他

6. 全球行動心電遙測設備市場（依最終用戶分類）

• 市場分析、洞察與預測
• 醫院
• 專科診所
• 診斷中心
• 居家醫療環境
• 其他

7. 全球行動心電遙測設備市場（按地區分類）

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第8章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商格局（基於現有資訊）
• 策略規劃

第9章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Biotelemetry Inc
  • Scottcare
  • Biotricity Inc
  • Welch Allyn
  • Applied Cardiac Systems Inc
  • Medicomp Inc
  • Preventice Solutions
  • Telerhythmics LLC
  • Zoll Medical Corporation
  • Irhythm Technologies Inc

The Mobile Cardiac Telemetry Device Market size is expected to reach USD 5.66 Billion in 2034 from USD 2.09 Billion (2025) growing at a CAGR of 11.72% during 2026-2034.

The Mobile Cardiac Telemetry Device market is poised for remarkable growth as the demand for remote patient monitoring and telehealth solutions continues to rise. With an increasing focus on preventive healthcare and the management of chronic conditions, mobile cardiac telemetry devices are becoming essential tools for healthcare providers. These devices enable continuous monitoring of patients' heart activity, allowing for timely interventions and improved patient outcomes. As technology advances, the integration of mobile telemetry with wearable devices and mobile applications will further enhance the accessibility and effectiveness of cardiac care.

As healthcare systems worldwide strive to reduce costs and improve patient engagement, mobile cardiac telemetry devices offer a viable solution for managing cardiovascular health. By enabling remote monitoring, these devices can reduce the need for hospital visits and allow healthcare providers to track patients' conditions in real-time. This shift not only enhances patient convenience but also empowers healthcare professionals to make informed decisions based on accurate and timely data.

Looking ahead, the Mobile Cardiac Telemetry Device market is expected to witness innovations that enhance device functionality and user experience. Developments in data analytics and artificial intelligence will enable more sophisticated monitoring capabilities, allowing for personalized treatment plans and proactive management of cardiac conditions. As the healthcare landscape continues to evolve, mobile cardiac telemetry devices will play a pivotal role in shaping the future of cardiovascular care, ensuring that patients receive timely and effective interventions.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Application

• Lead-Based
• Patch-Based

By Disease Indication

• Angina Pectoris
• Atherosclerosis
• Heart Failure
• Others

By End-User

• Hospitals
• Specialty Clinics
• Diagnostic Centers
• Home Care Settings
• Others

COMPANIES PROFILED

• Biotelemetry Inc, Scottcare, Biotricity Inc, Welch Allyn, Applied Cardiac Systems Inc, Medicomp Inc, Preventice Solutions, Telerhythmics LLC, Zoll Medical Corporation, Irhythm Technologies Inc

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL MOBILE CARDIAC TELEMETRY DEVICE MARKET: BY APPLICATION 2022-2034 (USD MN and K Units)

• 4.1. Market Analysis, Insights and Forecast Application
• 4.2. Lead-Based Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)
• 4.3. Patch-Based Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)

Chapter 5. GLOBAL MOBILE CARDIAC TELEMETRY DEVICE MARKET: BY DISEASE INDICATION 2022-2034 (USD MN and K Units)

• 5.1. Market Analysis, Insights and Forecast Disease Indication
• 5.2. Angina Pectoris Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)
• 5.3. Atherosclerosis Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)
• 5.4. Heart Failure Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)
• 5.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)

Chapter 6. GLOBAL MOBILE CARDIAC TELEMETRY DEVICE MARKET: BY END-USER 2022-2034 (USD MN and K Units)

• 6.1. Market Analysis, Insights and Forecast End-user
• 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)
• 6.3. Specialty Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)
• 6.4. Diagnostic Centers Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)
• 6.5. Home Care Settings Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)
• 6.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)

Chapter 7. GLOBAL MOBILE CARDIAC TELEMETRY DEVICE MARKET: BY REGION 2022-2034(USD MN and K Units)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN and K Units)
  • 7.2.1 By Application
  • 7.2.2 By Disease Indication
  • 7.2.3 By End-user
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN and K Units)
  • 7.3.1 By Application
  • 7.3.2 By Disease Indication
  • 7.3.3 By End-user
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN and K Units)
  • 7.4.1 By Application
  • 7.4.2 By Disease Indication
  • 7.4.3 By End-user
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN and K Units)
  • 7.5.1 By Application
  • 7.5.2 By Disease Indication
  • 7.5.3 By End-user
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN and K Units)
  • 7.6.1 By Application
  • 7.6.2 By Disease Indication
  • 7.6.3 By End-user
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL MOBILE CARDIAC TELEMETRY DEVICE INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Biotelemetry Inc
  • 9.2.2 Scottcare
  • 9.2.3 Biotricity Inc
  • 9.2.4 Welch Allyn
  • 9.2.5 Applied Cardiac Systems Inc
  • 9.2.6 Medicomp Inc
  • 9.2.7 Preventice Solutions
  • 9.2.8 Telerhythmics LLC
  • 9.2.9 Zoll Medical Corporation
  • 9.2.10 Irhythm Technologies Inc